gastrointestinal side effects
anticholinergic side effects
common cause of gastrointestinal complaints
dry mouth
constipation
nausea
pain/bloating/gas
anorexia
diarrhea
vomiting
cases of paralytic ileus
case of oral mucosal ulceration
sublingual use of disopyramide
cardiovascular
side effects
arrhythmias
conduction disturbances
hypotension
heart failure
other class
antiarrhythmic agents
disopyramide
cardiac contractility
risk of proarrhythmias
patients with left ventricular dysfunction
various ventricular tachyarrhythmias
disopyramide-induced qt interval prolongation
including
ventricular tachycardia
fibrillation
torsades de pointes
usual therapeutic doses
evidence of qrs segment
qt widening
indications
dose
drug
conduction disturbances
including av block
patients
preexisting conduction disorders
contributing factors towards the development of torsades de pointes
female gender
hypokalemia
underlying arrhythmias
mitral valve abnormalities
congestive heart failure
hypotension
pulmonary edema
frank cardiogenic shock
intravenous administration of disopyramide
most affected patients
underlying congestive heart failure
patient
severe sensory-motor polyneuropathy
receiving disopyramide mg
years
symptoms
corticosteroids
few months after withdrawal of disopyramide
nervous system
side effects
anticholinergic symptoms
other nervous system
side effects
nervousness
insomnia
depression
peripheral paresthesia
neuropathy
genitourinary side effects
anticholinergic properties of the drug
urinary hesitancy
urinary retention
frequency
urgency
patients
recommended management
lowering
dose
discontinuing
drug
using
cholinergic drug
effect
sexual impotence
hepatic side effects
dose-independent intrahepatic cholestasis
hepatocellular damage
nonspecific hepatic inflammatory changes
rare cases
venous congestion
heart failure
manifestations of liver dysfunction
first week of treatment
malaise
dark urine
discontinuation of the drug
review
cases
year period
endocrine side effect
hypoglycemia
stimulation of insulin secretion
rare cases of hypokalemia
dyslipidemia
hypoglycemia
nondiabetic patients at therapeutic plasma disopyramide levels
elevated insulin levels
disopyramide-associated hypoglycemic episodes
data
disopyramide
pancreatic atp-sensitive potassium channels
enhancing insulin release
other factors
increased peripheral utilization of glucose
decreased glycogenolysis
immunologic side effects
production of antinuclear antibodies
other immunologically-mediated changes
other class
antiarrhythmic agents
disopyramide therapy
dermatologic reactions
presenting as a rash
pruritus
ocular side effects
blurred vision
anticholinergic effects of disopyramide
general body symptoms of fatigue
muscle weakness
malaise
aches/pains
patients
administered disopyramide
fever
psychiatric side effects
reversible psychiatric symptoms of psychosis
hematologic adverse effects of thrombocytopenia
reversible agranulocytosis
gynecomastia
respiratory difficulty
dizziness
feeling of faintness
fainting 
heartbeat sensations
shortness of breath
unusual tiredness
chest pain
heartbeat
rapid weight gain
swelling of feet
lower legs
lightheadedness
rash and/or itching
enlargement of breasts in men
fever 
mental depression
nosebleeds
bleeding gums
sore throat
fever
yellow eyes
skin
anxious feeling
chills
cold sweats
confusion
cool, pale skin
drowsiness
fast heartbeat
headache
hunger (excessive)
nausea
nervousness
shakiness
unsteady walk
unusual tiredness
weakness
blurred vision
constipation
dry eyes
mouth
nose
throat
problems with urination
bloating
stomach pain
diarrhea
headache
impotence
loss of appetite
muscle weakness
nausea
nervousness
trouble in sleeping